Patient Capital Management’s State Street SPDR S&P 500 ETF Trust SPY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$726K Buy
1,115
+40
+4% +$27.2K 0.03% 40
2025
Q4
$733K Buy
1,075
+654
+155% +$442K 0.03% 40
2025
Q3
$281K Buy
+421
New +$270K 0.01% 41
2025
Q1
Sell
-3,463
Closed -$2.03M 42
2024
Q4
$2.03M Buy
3,463
+1,977
+133% +$1.16M 0.09% 40
2024
Q3
$852K Buy
1,486
+748
+101% +$414K 0.04% 40
2024
Q2
$402K Buy
+738
New +$386K 0.02% 40
2024
Q1
Sell
-2,091
Closed -$994K 44
2023
Q4
$994K Buy
+2,091
New +$931K 0.05% 42

Other funds holding SPY

Patient Capital Management's SPY Position: Q1 2026 in Review

Patient Capital Management increased its State Street SPDR S&P 500 ETF Trust (SPY) stake by 3.7% in Q1 2026, buying an estimated $27.2K and bringing the position to 1,115 shares worth $726K. The position accounts for 0.03% of the portfolio, ranked #40.

Patient Capital Management first reported a position in SPY in Q4 2023 and has held it in 7 quarters since. The position peaked at $2.03M in Q4 2024. 4,557 funds tracked by Wall St. Rank hold SPY as of Q1 2026.

  • Patient Capital Management held 1,115 shares of State Street SPDR S&P 500 ETF Trust worth $726K as of Q1 2026.
  • Patient Capital Management bought 40 State Street SPDR S&P 500 ETF Trust shares in Q1 2026, an estimated $27.2K.
  • State Street SPDR S&P 500 ETF Trust made up 0.03% of Patient Capital Management's portfolio in Q1 2026, its #40 holding.
  • Patient Capital Management first reported a position in State Street SPDR S&P 500 ETF Trust in Q4 2023 and has held it in 7 quarters since.
  • Patient Capital Management's State Street SPDR S&P 500 ETF Trust position peaked at $2.03M in Q4 2024.
  • 4,557 funds tracked by Wall St. Rank held State Street SPDR S&P 500 ETF Trust as of Q1 2026.

Based on Patient Capital Management's 13F filing for Q1 2026, filed 14 May 2026.